Cargando…
P948: INCIDENCE AND CLINICAL OUTCOME OF SARS-COV-2 INFECTION AFTER VACCINATION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429539/ http://dx.doi.org/10.1097/01.HS9.0000846660.15920.42 |
| _version_ | 1784779476130856960 |
|---|---|
| author | Sgherza, N. Curci, P. Rizzi, R. Roccotelli, D. Croce, M. Avantaggiato, M. Ruga, L. Vitucci, A. Palma, A. Di Gennaro, D. Musto, P. |
| author_facet | Sgherza, N. Curci, P. Rizzi, R. Roccotelli, D. Croce, M. Avantaggiato, M. Ruga, L. Vitucci, A. Palma, A. Di Gennaro, D. Musto, P. |
| author_sort | Sgherza, N. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429539 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94295392022-08-31 P948: INCIDENCE AND CLINICAL OUTCOME OF SARS-COV-2 INFECTION AFTER VACCINATION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) Sgherza, N. Curci, P. Rizzi, R. Roccotelli, D. Croce, M. Avantaggiato, M. Ruga, L. Vitucci, A. Palma, A. Di Gennaro, D. Musto, P. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429539/ http://dx.doi.org/10.1097/01.HS9.0000846660.15920.42 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Sgherza, N. Curci, P. Rizzi, R. Roccotelli, D. Croce, M. Avantaggiato, M. Ruga, L. Vitucci, A. Palma, A. Di Gennaro, D. Musto, P. P948: INCIDENCE AND CLINICAL OUTCOME OF SARS-COV-2 INFECTION AFTER VACCINATION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) |
| title | P948: INCIDENCE AND CLINICAL OUTCOME OF SARS-COV-2 INFECTION AFTER VACCINATION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) |
| title_full | P948: INCIDENCE AND CLINICAL OUTCOME OF SARS-COV-2 INFECTION AFTER VACCINATION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) |
| title_fullStr | P948: INCIDENCE AND CLINICAL OUTCOME OF SARS-COV-2 INFECTION AFTER VACCINATION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) |
| title_full_unstemmed | P948: INCIDENCE AND CLINICAL OUTCOME OF SARS-COV-2 INFECTION AFTER VACCINATION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) |
| title_short | P948: INCIDENCE AND CLINICAL OUTCOME OF SARS-COV-2 INFECTION AFTER VACCINATION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) |
| title_sort | p948: incidence and clinical outcome of sars-cov-2 infection after vaccination in patients with monoclonal gammopathy of undetermined significance (mgus) |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429539/ http://dx.doi.org/10.1097/01.HS9.0000846660.15920.42 |
| work_keys_str_mv | AT sgherzan p948incidenceandclinicaloutcomeofsarscov2infectionaftervaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus AT curcip p948incidenceandclinicaloutcomeofsarscov2infectionaftervaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus AT rizzir p948incidenceandclinicaloutcomeofsarscov2infectionaftervaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus AT roccotellid p948incidenceandclinicaloutcomeofsarscov2infectionaftervaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus AT crocem p948incidenceandclinicaloutcomeofsarscov2infectionaftervaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus AT avantaggiatom p948incidenceandclinicaloutcomeofsarscov2infectionaftervaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus AT rugal p948incidenceandclinicaloutcomeofsarscov2infectionaftervaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus AT vituccia p948incidenceandclinicaloutcomeofsarscov2infectionaftervaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus AT palmaa p948incidenceandclinicaloutcomeofsarscov2infectionaftervaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus AT digennarod p948incidenceandclinicaloutcomeofsarscov2infectionaftervaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus AT mustop p948incidenceandclinicaloutcomeofsarscov2infectionaftervaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus |